SAM
GBT
Sectoral Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-255,271
| Closed | -$14.1M | – | 109 |
|
|
2020
Q3 | $14.1M | Buy |
255,271
+26,000
| +11% | +$1.43M | 1.21% | 34 |
|
|
2020
Q2 | $14.5M | Buy |
229,271
+51,977
| +29% | +$3.28M | 1.33% | 32 |
|
|
2020
Q1 | $9.06M | Buy |
177,294
+2,700
| +2% | +$138K | 1.74% | 20 |
|
|
2019
Q4 | $13.9M | Sell |
174,594
-66,446
| -28% | -$5.28M | 2.07% | 22 |
|
|
2019
Q3 | $11.7M | Buy |
241,040
+14,799
| +7% | +$718K | 2.02% | 19 |
|
|
2019
Q2 | $11.9M | Sell |
226,241
-47,100
| -17% | -$2.48M | 1.42% | 26 |
|
|
2019
Q1 | $14.5M | Sell |
273,341
-9,200
| -3% | -$487K | 1.74% | 19 |
|
|
2018
Q4 | $11.6M | Buy |
282,541
+44,500
| +19% | +$1.83M | 1.58% | 22 |
|
|
2018
Q3 | $9.05M | Buy |
238,041
+7,347
| +3% | +$279K | 0.96% | 40 |
|
|
2018
Q2 | $10.4M | Buy |
230,694
+43,700
| +23% | +$1.98M | 1.17% | 34 |
|
|
2018
Q1 | $9.03M | Sell |
186,994
-254,774
| -58% | -$12.3M | 0.99% | 39 |
|
|
2017
Q4 | $17.4M | Sell |
441,768
-91,940
| -17% | -$3.62M | 2.17% | 19 |
|
|
2017
Q3 | $16.6M | Buy |
533,708
+80,927
| +18% | +$2.51M | 2.13% | 23 |
|
|
2017
Q2 | $12.4M | Buy |
452,781
+107,199
| +31% | +$2.93M | 1.35% | 29 |
|
|
2017
Q1 | $12.7M | Sell |
345,582
-780,219
| -69% | -$28.8M | 1.49% | 28 |
|
|
2016
Q4 | $16.3M | Buy |
1,125,801
+94,352
| +9% | +$1.36M | 1.8% | 23 |
|
|
2016
Q3 | $23.8M | Buy |
1,031,449
+44,225
| +4% | +$1.02M | 2.33% | 18 |
|
|
2016
Q2 | $16.4M | Buy |
+987,224
| New | +$16.4M | 1.69% | 26 |
|